We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
-3.06%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$77.7B
AUM Growth
-$3.9B
Cap. Flow
+$505M
Cap. Flow %
0.65%
Top 10 Hldgs %
24.09%
Holding
3,066
New
55
Increased
1,481
Reduced
1,461
Closed
51

Top Buys

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$83.5M
2
SPGI icon
S&P Global
SPGI
+$73.5M
3
TSLA icon
Tesla
TSLA
+$55.8M
4
MSFT icon
Microsoft
MSFT
+$45.9M
5
AMZN icon
Amazon
AMZN
+$27.9M

Top Sells

Rank Stock Value
1
XLNX
Xilinx Inc
XLNX
+$88.8M
2
INFO
IHS Markit Ltd. Common Shares
INFO
+$74.7M
3
CONE
CyrusOne Inc Common Stock
CONE
+$31.7M
4
ABT icon
Abbott
ABT
+$25.5M
5
EXC icon
Exelon
EXC
+$23.2M

Sector Composition

Rank Sector Weight
1 Technology 24.74%
2 Financials 13.53%
3 Healthcare 13.01%
4 Consumer Discretionary 11.66%
5 Industrials 8.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PASG icon
2826
Passage Bio
PASG
$14.1M
$144K ﹤0.01%
2,328
-51
-2% -$4.2K
EMKR
2827
DELISTED
Emcore Corp
EMKR
$144K ﹤0.01%
3,902
+28
+0.7% +$1.34K
TCRT icon
2828
Alaunos Therapeutics
TCRT
$4.86M
$143K ﹤0.01%
1,460
-10
-0.7% -$1.28K
ICVX
2829
DELISTED
Icosavax, Inc. Common Stock
ICVX
$143K ﹤0.01%
20,362
+8,073
+66% +$127K
DRRX
2830
DELISTED
DURECT Corp
DRRX
$140K ﹤0.01%
20,916
+280
+1% +$1.95K
HGEN
2831
DELISTED
HUMANIGEN, INC.
HGEN
$140K ﹤0.01%
46,361
+1,354
+3% +$3.62K
VHC icon
2832
VirnetX Holding Corp
VHC
$63.1M
$139K ﹤0.01%
4,277
-366
-8% -$15K
TLMD
2833
DELISTED
SOC Telemed, Inc. Class A Common Stock
TLMD
$139K ﹤0.01%
46,413
+13,506
+41% +$29.7K
BYRN icon
2834
Byrna Technologies
BYRN
$101M
$138K ﹤0.01%
16,877
+4,320
+34% +$44K
TRHC
2835
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$138K ﹤0.01%
23,956
-32,576
-58% -$292K
FWRG icon
2836
First Watch Restaurant Group
FWRG
$766M
$137K ﹤0.01%
+10,507
New +$151K
ASXC
2837
DELISTED
Asensus Surgical, Inc.
ASXC
$137K ﹤0.01%
218,056
-40,417
-16% -$31.1K
DLTH icon
2838
Duluth Holdings
DLTH
$159M
$136K ﹤0.01%
11,123
+521
+5% +$7.29K
RNAC icon
2839
Cartesian Therapeutics
RNAC
$268M
$134K ﹤0.01%
3,618
+2
+0.1% +$125
SFT
2840
DELISTED
Shift Technologies, Inc. Class A Common Stock
SFT
$133K ﹤0.01%
6,029
-658
-10% -$14.6K
PRTK
2841
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$132K ﹤0.01%
44,588
-7,567
-15% -$28.5K
ALIT icon
2842
Alight
ALIT
$407M
$129K ﹤0.01%
+647
New +$127K
CTSO icon
2843
Cytosorbents Corp
CTSO
$22.6M
$128K ﹤0.01%
40,176
-16
-0% -$57
SIEN
2844
DELISTED
Sientra, Inc.
SIEN
$128K ﹤0.01%
5,756
+26
+0.5% +$712
AKUS
2845
DELISTED
Akouos Inc
AKUS
$127K ﹤0.01%
26,649
-822
-3% -$4.82K
LENZ
2846
LENZ Therapeutics
LENZ
$168M
$126K ﹤0.01%
3,523
+1,854
+111% +$116K
TYRA icon
2847
Tyra Biosciences
TYRA
$1.58B
$125K ﹤0.01%
+11,726
New +$139K
USX
2848
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
$125K ﹤0.01%
32,236
-3,539
-10% -$15.9K
OLMA icon
2849
Olema Pharmaceuticals
OLMA
$1.05B
$122K ﹤0.01%
28,682
+2,335
+9% +$12.9K
JOAN
2850
DELISTED
JOANN, Inc. Common Stock
JOAN
$122K ﹤0.01%
+10,685
New +$120K
112 113
114
115 116

Similar funds

VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

RhumbLine Advisers's Q1 2022 Portfolio in Review

As of Q1 2022, RhumbLine Advisers held 3,066 positions worth $77.7B, down 4.8% from $81.6B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Trading was light in Q1 2022: portfolio turnover was 3.5%. RhumbLine Advisers opened 55 new positions and exited 51, leaving the 3,066-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q1 2022 buy was Constellation Energy: 528,261 shares worth $29.7M.
  • RhumbLine Advisers added most to Advanced Micro Devices in Q1 2022, an estimated $83.5M increase.
  • RhumbLine Advisers's biggest Q1 2022 reduction was Abbott, cutting an estimated $25.5M.
  • RhumbLine Advisers fully exited Xilinx Inc in Q1 2022, selling an estimated $88.8M.
  • RhumbLine Advisers's ten largest holdings make up 24% of its $77.7B portfolio in Q1 2022.
  • RhumbLine Advisers opened 55 new positions and closed 51 in Q1 2022.
  • RhumbLine Advisers's portfolio value fell 4.8% quarter-over-quarter to $77.7B.

Based on RhumbLine Advisers's 13F filing for Q1 2022, filed 12 May 2022.